Meticulous Research®—a leading global market research company, published a research report titled, ‘Psoriasis Treatment Market Size, Share, Forecast, & Trends Analysis by Treatment (TNF Inhibitor, Interleukin, Corticosteroids, Calcitrol, Retinoids, Calcineurin, Methotrexate) Disease (Plaque Psoriasis, Psoriatic Arthritis) – Global Forecast to 2031.’
The psoriasis treatment market is projected to experience significant growth, with a market size expected to reach $35.07 billion by 2031. This growth is driven by various factors including the high burden of psoriasis, advancements in treatment options, and an improved understanding of the disease. Additionally, the rising awareness regarding psoriasis, the growing use of combination therapies for treatment, and increasing research in the field are expected to generate substantial growth opportunities for market players.
Psoriasis Treatment Market Growth Drivers
• High Burden of Psoriasis
Psoriasis, a chronic autoimmune disorder, manifests as red, scaly patches on the skin, often accompanied by itching, pain, and discomfort. The physical and emotional impact of psoriasis is profound, leading to feelings of embarrassment, self-consciousness, and low self-esteem among affected individuals. According to the National Psoriasis Foundation, around 125 million people, or 2-3% of the global population, are affected by psoriasis. This significant global burden necessitates ongoing treatment and drives the demand for effective psoriasis treatments.
• Elevated Susceptibility of Elderly Individuals to Psoriasis
The elderly population is at a higher risk of developing psoriasis due to a weakened immune system and age-related skin changes. Older individuals often contend with chronic ailments or medications that can trigger or worsen psoriasis. The increasing global population of individuals aged 65 and above, projected to rise from 10% in 2022 to 16% by 2025, further fuels the demand for psoriasis treatments.
Psoriasis Treatment Market Trends
1. Targeted Therapy/Personalized Medicine
Personalized medicine is becoming a cornerstone in psoriasis treatment, tailoring therapy to the unique characteristics of each patient. Advanced diagnostic tools like biomarker-based diagnostics and genetic testing enable healthcare providers to select the most suitable treatment options, enhancing treatment effectiveness and minimizing side effects. This approach promises improved patient outcomes and satisfaction in managing psoriasis.

2. Steroid-free Topicals
The shift towards steroid-free topicals reflects a growing demand for safer and more sustainable therapeutic options. These formulations, utilizing ingredients like calcineurin inhibitors or vitamin D analogs, provide effective relief from psoriasis symptoms without the side effects associated with prolonged steroid use. Steroid-free topicals are emerging as a promising option for managing mild to moderate psoriasis.
3. Growing Use of Combination Therapies for Treatment
Combination therapies involve using multiple treatment modalities simultaneously to enhance efficacy and address various aspects of the disease. This approach is particularly useful for patients with moderate to severe psoriasis or those unresponsive to monotherapy. Combining topical treatments with phototherapy or systemic medications with biologic agents can provide comprehensive management of psoriasis. This personalized approach to treatment aligns with the increasing demand for tailored healthcare solutions, presenting significant opportunities for market players.
Psoriasis Treatment Market Analysis: Key Findings
• By Treatment Type: Biologic Drugs Segment to Dominate in 2024
Based on treatment type, the market is segmented into biologic drugs, topical treatments, and systemic treatments. In 2024, the biologic drugs segment is expected to account for the largest share of the psoriasis treatment market, attributed to their high efficacy and targeted approach in treating moderate to severe psoriasis. The segment is also projected to witness the highest growth rate during the forecast period, driven by the increasing acceptance of interleukin inhibitors and ongoing research and development efforts.
• By Disease Type: Plaque Psoriasis Segment to Dominate in 2024
Based on disease type, the psoriasis treatment market is segmented into plaque psoriasis, psoriatic arthritis, and others. The plaque psoriasis segment is expected to account for the largest share in 2024, driven by the high prevalence of plaque psoriasis, improved diagnostic techniques, and the growing use of combination therapies. The psoriatic arthritis segment is anticipated to grow at the highest CAGR during the forecast period, reflecting heightened awareness and advancements in diagnostic techniques.

• By Administration Route: Injectable Segment to Dominate in 2024
Based on administration route, the market is segmented into oral, topical, and injectable. The injectable segment is expected to account for the largest share in 2024, driven by the increasing adoption of biologic therapies. Advancements in injection technology, such as prefilled syringes and autoinjectors, enhance patient convenience and comfort, further amplifying the demand for injectable medications.
• By Distribution Channel: Hospital Pharmacies Segment to Dominate in 2024
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online/e-commerce platforms. In 2024, the hospital pharmacies segment is expected to account for the largest share of the market, attributed to hospitals being primary hubs for diagnosing and treating psoriasis. The online/e-commerce platforms segment is expected to grow at the highest CAGR during the forecast period, driven by the convenience and accessibility of online shopping.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5908

Geographical Analysis
In 2024, North America is expected to account for the largest share of the psoriasis treatment market, driven by the high prevalence of psoriasis and the adoption of personalized therapies. The U.S. will lead the market in North America, benefiting from a well-developed health infrastructure and continuous research and development efforts. However, the Asia-Pacific region is anticipated to register the highest CAGR during the forecast period, driven by the rising prevalence of psoriasis, increasing demand for quality healthcare, and a large population base. Government initiatives and the launch of advanced treatment options are also contributing to market growth in this region.

Key questions answered in the report-
• What is the current value of revenue generated by medicines for psoriasis across the globe?
• At what rate is the demand for psoriasis treatment projected to grow for the next 5-7 years?
• What is the historical market size and growth rate for psoriasis treatment across the globe?
• What are the major factors impacting the growth of this market at the global and regional levels? What are the major opportunities for existing market players and new entrants in the market?
• Which segments are creating major traction for the vendors in this market in terms of treatment type, disease type, route of administration, and distribution channel?
• What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the psoriasis treatment market?
• Who are the major players in the psoriasis treatment market? And what are their specific apps offered in the industry?
• What recent developments have taken place in the psoriasis treatment market, and how these strategic developments are creating a global impact in this market?

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research